Lexaria Bioscience Corp. (LEXX)
2.88
-0.21
(-6.80%)
USD |
NASDAQ |
Oct 02, 16:00
2.77
-0.11
(-3.82%)
After-Hours: 20:00
Lexaria Bioscience Net Income (Quarterly) : -1.993M for May 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.993M |
| February 28, 2026 | -1.453M |
| November 30, 2025 | -1.598M |
| August 31, 2025 | -2.697M |
| May 31, 2025 | -3.791M |
| February 28, 2025 | -2.717M |
| November 30, 2024 | -2.707M |
| August 31, 2024 | -2.187M |
| May 31, 2024 | -1.784M |
| February 29, 2024 | -0.6527M |
| November 30, 2023 | -1.185M |
| May 31, 2023 | -2.384M |
| February 28, 2023 | -1.311M |
| November 30, 2022 | -1.769M |
| August 31, 2022 | -1.513M |
| May 31, 2022 | -2.418M |
| February 28, 2022 | -1.449M |
| November 30, 2021 | -2.004M |
| August 31, 2021 | -1.303M |
| May 31, 2021 | -2.567M |
| February 28, 2021 | 0.4182M |
| November 30, 2020 | -0.7131M |
| August 31, 2020 | -0.8628M |
| May 31, 2020 | -1.410M |
| February 29, 2020 | -1.062M |
| Date | Value |
|---|---|
| November 30, 2019 | -0.9761M |
| August 31, 2019 | -1.116M |
| May 31, 2019 | -1.193M |
| February 28, 2019 | -1.153M |
| November 30, 2018 | -0.7014M |
| August 31, 2018 | -1.227M |
| May 31, 2018 | -3.425M |
| February 28, 2018 | -1.378M |
| November 30, 2017 | -0.5787M |
| August 31, 2017 | -0.7198M |
| May 31, 2017 | -0.3441M |
| February 28, 2017 | -0.465M |
| November 30, 2016 | -0.4006M |
| August 31, 2016 | -0.3267M |
| May 31, 2016 | -0.2642M |
| February 29, 2016 | -0.2746M |
| November 30, 2015 | -0.4117M |
| August 31, 2015 | -0.6156M |
| May 31, 2015 | -0.511M |
| February 28, 2015 | -0.4586M |
| November 30, 2014 | -0.3981M |
| July 31, 2014 | -0.5764M |
| April 30, 2014 | -0.4933M |
| January 31, 2014 | -0.1019M |
| October 31, 2013 | -0.1263M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | -0.2398M |
| InMed Pharmaceuticals, Inc. | -4.843M |
| XORTX Therapeutics, Inc. | -1.691M |
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.991M |
| EPS Diluted (Quarterly) | -1.204 |
| Enterprise Value | 0.8348M |
| Earnings Yield | -183.4% |
| Normalized Earnings Yield | -178.78 |